Karimian-Jazi, Kianush et al "Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI." Neurology - Neuroimmunology Neuroinflammation 5.5 (2018): e480. Web. 20 Oct. 2018.